亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

ProGleason-GAN: Conditional progressive growing GAN for prostatic cancer Gleason grade patch synthesis

计算机科学 前列腺癌 样品(材料) 人工智能 公制(单位) 过程(计算) 接收机工作特性 前列腺 模式识别(心理学) 机器学习 癌症 医学 算法 内科学 经济 操作系统 化学 色谱法 运营管理
作者
Alejandro Golfe,Rocío del Amor,Adrián Colomer,María A. Sales,Liria Terrádez,Valery Naranjo
出处
期刊:Computer Methods and Programs in Biomedicine [Elsevier]
卷期号:240: 107695-107695 被引量:6
标识
DOI:10.1016/j.cmpb.2023.107695
摘要

Prostate cancer is one of the most common diseases affecting men. The main diagnostic and prognostic reference tool is the Gleason scoring system. An expert pathologist assigns a Gleason grade to a sample of prostate tissue. As this process is very time-consuming, some artificial intelligence applications were developed to automatize it. The training process is often confronted with insufficient and unbalanced databases which affect the generalisability of the models. Therefore, the aim of this work is to develop a generative deep learning model capable of synthesising patches of any selected Gleason grade to perform data augmentation on unbalanced data and test the improvement of classification models.The methodology proposed in this work consists of a conditional Progressive Growing GAN (ProGleason-GAN) capable of synthesising prostate histopathological tissue patches by selecting the desired Gleason Grade cancer pattern in the synthetic sample. The conditional Gleason Grade information is introduced into the model through the embedding layers, so there is no need to add a term to the Wasserstein loss function. We used minibatch standard deviation and pixel normalisation to improve the performance and stability of the training process.The reality assessment of the synthetic samples was performed with the Frechet Inception Distance (FID). We obtained an FID metric of 88.85 for non-cancerous patterns, 81.86 for GG3, 49.32 for GG4 and 108.69 for GG5 after post-processing stain normalisation. In addition, a group of expert pathologists was selected to perform an external validation of the proposed framework. Finally, the application of our proposed framework improved the classification results in SICAPv2 dataset, proving its effectiveness as a data augmentation method.ProGleason-GAN approach combined with a stain normalisation post-processing provides state-of-the-art results regarding Frechet's Inception Distance. This model can synthesise samples of non-cancerous patterns, GG3, GG4 or GG5. The inclusion of conditional information about the Gleason grade during the training process allows the model to select the cancerous pattern in a synthetic sample. The proposed framework can be used as a data augmentation method.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
轻松的项链完成签到,获得积分10
1秒前
庞喜存v发布了新的文献求助10
1秒前
鼠鼠我啊发布了新的文献求助10
3秒前
顾矜应助林林采纳,获得10
6秒前
3089ggf完成签到,获得积分10
7秒前
11秒前
13秒前
13秒前
17秒前
林林发布了新的文献求助10
17秒前
珍惜发布了新的文献求助10
22秒前
寻一洲完成签到,获得积分10
22秒前
23秒前
26秒前
金林彤发布了新的文献求助10
29秒前
今后应助美丽的帆布鞋采纳,获得10
29秒前
CodeCraft应助123456采纳,获得10
30秒前
旧残月发布了新的文献求助10
33秒前
homeless完成签到 ,获得积分10
35秒前
王圣翔完成签到 ,获得积分10
37秒前
听话的八宝粥完成签到 ,获得积分10
38秒前
38秒前
43秒前
好困完成签到 ,获得积分10
44秒前
ADJ完成签到,获得积分10
47秒前
星星有梦做完成签到 ,获得积分10
47秒前
123456发布了新的文献求助10
47秒前
思源应助金林彤采纳,获得10
48秒前
凉宫八月完成签到,获得积分10
48秒前
48秒前
lily完成签到 ,获得积分10
50秒前
迫切完成签到,获得积分10
51秒前
华仔应助坤桑采纳,获得10
53秒前
有何可不完成签到,获得积分10
1分钟前
CodeCraft应助ccccc采纳,获得10
1分钟前
彦卿完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6020845
求助须知:如何正确求助?哪些是违规求助? 7623082
关于积分的说明 16165681
捐赠科研通 5168555
什么是DOI,文献DOI怎么找? 2766100
邀请新用户注册赠送积分活动 1748479
关于科研通互助平台的介绍 1636086